A novel fragment derived from the beta chain of human fibrinogen, beta 43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo

Krajewska, E., Lewis, C.E., Chen, Y.Y. et al. (3 more authors) (2010) A novel fragment derived from the beta chain of human fibrinogen, beta 43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo. British Journal of Cancer, 102 (3). pp. 594-601. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Krajewska, E.
  • Lewis, C.E.
  • Chen, Y.Y.
  • Welford, A.
  • Tazzyman, S.
  • Staton, C.A.
Copyright, Publisher and Additional Information: © 2010 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: fibrinogen; beta 43-63; endothelial; anti-angiogenic; haemostasis; growth-factor receptor-2; alpha(v)beta(3) integrin; extracellular-matrix; angiogenesis; binding; cancer; tumstatin; migration; adhesion; peptide
Dates:
  • Published: 2 February 2010
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 28 Nov 2016 10:29
Last Modified: 28 Nov 2016 10:36
Published Version: http://dx.doi.org/10.1038/sj.bjc.6605495
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6605495

Share / Export

Statistics